BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

EDISON OPEN HOUSE 2022, page-2

  1. 805 Posts.
    lightbulb Created with Sketch. 471
    Thanks. A few interesting things I took from that:

    - Canine AD spin-off possibly on the cards
    - New non-cannabinoid assets coming (presumably using Permetrex)
    - Setting up to be an M&A target in around 18-24 months.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.